BioSpace News Archive

Merck, known as MSD outside of the United States and Canada, announced that Jannie Oosthuizen, president, Human Health U.S., is scheduled to participate in a fireside chat at the UBS BioPharma Conference on Wednesday.

ADMA Biologics, Inc. announced that it will report third quarter 2023 financial results on November 8, 2023, after the U.S. financial markets close.

Matinas BioPharma Holdings, Inc. announces that it will report third quarter 2023 financial results after market close on Wednesday, November 8, 2023.

Amicus Therapeutics announced that management will participate in upcoming presentations at the following investor conferences in November.

PolyPid Ltd., a late-stage biopharma company aiming to improve surgical outcomes, announced that it will report its third quarter 2023 financial results and operational highlights before the open of the U.S. financial markets on Wednesday, November 8, 2023.

Amarin Corporation plc announced financial results for the quarter ended September 30, 2023 and provided an update on company operations.

Atea Pharmaceuticals, Inc. announced that it will host a live conference call and audio webcast on Wednesday, November 8, 2023, at 4:30 p.m. ET to report financial results for the third quarter ended September 30, 2023, and to provide a business update.

Monopar Therapeutics Inc. will present data from its ongoing Phase 1b open-label, dose-escalating clinical trial of camsirubicin in patients with advanced soft tissue sarcoma later at the 2023 Connective Tissue Oncology Society Annual Meeting, which is bringing together the world’s leading sarcoma specialists.

Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company redefining neuroscience drug development, announced financial results for the third quarter ended September 30, 2023 and provided a general business update.

Apellis Pharmaceuticals, Inc. announced its third quarter 2023 financial results and business highlights.